Malick M. Gibani - Concepedia

Author

Malick M. Gibani

Also Known As

M Gibani, M. Gibani, M. M. Gibani, MM Gibani, Malick Gibani, Malick M Gibani, Malick M. Gibani, Malick MM Gibani, S. Fernandez Lopez

Publications

4.6K

Citations

H-Index

Concepts

All Affiliations

University of Oxford Oxford BioMedica (United Kingdom)Imperial College London National Institute for Health Research University of Liverpool

About

Malick M. Gibani is an author at University of Oxford specializing in medicine, immunology, and infection control.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	1.4K
2	Public Health	2	2	165
3	Epidemiology	2	2	165
4	Global Health	2	2	165
5	Cell Biology	1	1	34

Malick M. Gibani

Publications

Citations

H-Index

Page 1

	Year	Citations
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Eugenia Abaleke, Mustafa Abbas, Sadia Abbasi, The Lancet Long CovidAntimicrobial StewardshipAntibioticsClinical InfectionPlatform Trial	2021	555
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial Obbina Abani, Ali Abbas, Fatima Abbas, The Lancet	2021	516
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Obbina Abani, Ali Abbas, Fatima Abbas, The Lancet Covid-19 PandemicAntiviral TherapyClinical TrialsPlatform TrialMedicine	2022	382
A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVA Katie Ewer, Tommy Rampling, Navin Venkatraman, New England Journal of Medicine	2015	353
Safety and Immunogenicity of Novel Adenovirus Type 26– and Modified Vaccinia Ankara–Vectored Ebola Vaccines Iain Milligan, Malick M. Gibani, Richard P. Sewell, JAMA	2016	321
Efficacy and immunogenicity of a Vi-tetanus toxoid conjugate vaccine in the prevention of typhoid fever using a controlled human infection model of Salmonella Typhi: a randomised controlled, phase 2b trial Celina Jin, Malick M. Gibani, Maria Moore, The Lancet	2017	308
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Obbina Abani, Ali Abbas, Fatima Abbas, The Lancet	2021	289
Safety and immunogenicity of a two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Europe (EBOVAC2): a randomised, observer-blind, participant-blind, placebo-controlled, phase 2 trial Andrew J. Pollard, Odile Launay, Jean‐Daniel Lelièvre, The Lancet Infectious Diseases VaccinationVaccine SafetyVaccinologyTwo-dose Heterologous Ad26.zebovVaccine Surveillance	2020	164
Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial Obbina Abani, Ali Abbas, Fatima Abbas, The Lancet	2023	126
Assessing a novel, lab-free, point-of-care test for SARS-CoV-2 (CovidNudge): a diagnostic accuracy study Malick M. Gibani, C. Toumazou, Mohammadreza Sohbati, The Lancet Microbe	2020	114

Page 1